APA (7th ed.) Citation

Mano, Y., & Mizuo, H. (2019). Minimal impact of hepatic and renal impairment on plasma protein binding of lenvatinib, and identification of its major plasma binding protein. Biopharmaceutics & drug disposition, 40(8), 307-311. https://doi.org/10.1002/bdd.2204

Chicago Style (17th ed.) Citation

Mano, Yuji, and Hitoshi Mizuo. "Minimal Impact of Hepatic and Renal Impairment on Plasma Protein Binding of Lenvatinib, and Identification of Its Major Plasma Binding Protein." Biopharmaceutics & Drug Disposition 40, no. 8 (2019): 307-311. https://doi.org/10.1002/bdd.2204.

MLA (9th ed.) Citation

Mano, Yuji, and Hitoshi Mizuo. "Minimal Impact of Hepatic and Renal Impairment on Plasma Protein Binding of Lenvatinib, and Identification of Its Major Plasma Binding Protein." Biopharmaceutics & Drug Disposition, vol. 40, no. 8, 2019, pp. 307-311, https://doi.org/10.1002/bdd.2204.